Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model.

about

Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model.

Item

http://www.wikidata.org/entity/Q47578009

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@en

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@nl

type

Item

label

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@en

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@nl

prefLabel

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@en

Sex-specific risk assessment o ...... y based pharmacokinetic model.

@nl

P1476

Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model

@en

P2093

Hwajin Shin

http://www.w3.org/2001/XMLSchema#string

Sook-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Bok Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Allometric scaling of xenobiotic clearance: uncertainty versus universality

To scale or not to scale: the principles of dose extrapolation

Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths.

Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.

Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers

Cumulative health risk assessment of 17 perfluoroalkylated and polyfluoroalkylated substances (PFASs) in the Swedish population.

Hazard quotient profiles used as a risk assessment tool for PFOS and PFOA serum levels in three distinctive European populations.

Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.

Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010

P2888

s00204-017-2116-5

P304

1113-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00204-017-2116-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hea-Young Cho

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29143853

http://www.w3.org/2001/XMLSchema#string